NCT04546698View on ClinicalTrials.gov

5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

78

Participants

Timeline

Start Date

September 7, 2020

Primary Completion Date

July 19, 2021

Study Completion Date

July 19, 2021

Conditions
Multiple Sclerosis, Acute RelapsingMultiple Sclerosis
Interventions
OTHER

blood sampling

Analyse of expression modulation of 5-HT7 receptor in correlation with the immunological context, in 3 differents groups : 2 with multiple sclerosis patients, one healthy volunteers group

Trial Locations (1)

45067

CHR Orléans, Orléans

All Listed Sponsors
collaborator

National Scientific Research Centre

UNKNOWN

lead

Centre Hospitalier Régional d'Orléans

OTHER

NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis | Biotech Hunter | Biotech Hunter